Bilal Arif
Chief Tech/Sci/R&D Officer presso SAREPTA THERAPEUTICS, INC.
Patrimonio netto: 3 M $ in data 31/03/2024
Posizioni attive di Bilal Arif
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2022 | - |
| Corporate Officer/Principal | - | 31/12/2022 |
Storia della carriera di Bilal Arif
Precedenti posizioni note di Bilal Arif
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2017 | 02/01/2019 |
Formazione di Bilal Arif
| McGill University | Undergraduate Degree |
| Tufts University | Graduate Degree |
| Instituto de Empresa SL | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Canada | 2 |
| Spagna | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Bilal Arif
- Esperienza
